The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTPG.L Regulatory News (TPG)

  • There is currently no data for TPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

31 Oct 2022 07:00

RNS Number : 5785E
TP Group PLC
31 October 2022
 

This announcement contains inside information 

31 October 2022

 

TP Group plc

("TP Group", "Group" or "Company")

 

Business Update

 

Following the investment by Science Group plc and the subsequent Board changes, the strategy for TP Group was set out on 1 November 2021. The Board has regularly updated shareholders on the execution of that strategy, including the restructuring of the Group and the substantial challenges associated with the legacy contracts in the Maritime Division which have been well documented in the TP Group 2021 Annual Report and the 2022 Interim Results together with other announcements made over the past year. The Board now provides a further update to shareholders.

 

Maritime Division Contracts

 

The TPG Maritime division provides products and services associated with air handling systems for submarines. This is a specialist defence industry business with a small but international client base. In 2021, the TPG Maritime Division ("TPGM") had seven major customers, defined as revenue in excess of £0.5m in the year. Of those major clients, five contracts required priority renegotiation or termination. A summary of the current status of these contracts is as follows :

 

Contract A (UK Customer) : The overspend on this large, fixed price contract only became apparent early in 2022, resulting in material provisions and prior year adjustments as previously reported. Continuing with this very onerous contract in its original form was not financially viable for TPGM, placing the business at serious risk of insolvency. As a result of a protracted negotiation, agreement has now been reached with the customer such that the contract has been restructured as a Qualifying Sub-Contract, mitigating future exposure. While the margin associated with this contract will be significantly lower than had been originally anticipated and the terms remain sub-optimal, the Board concluded that it is in the best interests of all stakeholders to accept this compromise in relation to the current supply obligations but that any future product supply would require alternative contract arrangements.

 

Contract B (European Customer) : An agreement has been reached to settle the legacy liabilities and the customer wishes TPGM to complete the supply programme on the revised terms. The settlement includes a potential payment by TPGM of up to £0.4 million which may be reduced subject to future performance.

 

Contract C (European Customer) and Contract D (Asian Customer) : Progress has been made with these clients, resulting in a reasonable probability, but no certainty, of a satisfactory compromise. Negotiations are continuing.

 

Contract E (Hydrogen-powered train project) : TPGM had been acting as the reseller intermediary between a US supplier and a UK client in relation to this diversification. TPGM has agreed terms in principle with the other parties to exit this arrangement.

 

Of the remaining customers, it should be noted that a large UK consumables support contract is subject to re-tender in the next year. This contract accounted for approximately one third of TPGM revenue in 2021 and a greater proportion in the first half of 2022, although the gross margin is low. TPGM anticipates bidding to renew this contract but there can be no certainty as to the outcome.

 

As part of the contract renegotiations, the Board has removed or terminated parent company guarantees previously provided by TP Group plc to TPGM. Such guarantees potentially undermine the principle of limited liability of the subsidiary, exposing the Group to the TPGM liabilities and potentially inhibiting the Board's options.

 

TPG Services Division

 

The Services division has continued to perform satisfactorily with a continued focus on improving contract margins. The integration of Osprey, initiated over the summer, is progressing well with increasing alignment of strategic, operational and financial objectives.

 

Opportunities for collaboration between TPG Services and the Science Group R&D Division have been identified and are being developed by the respective operating management teams. Such cooperation should enable these businesses to offer new service capabilities into defence industry clients.

 

Westek

 

Following the disposal of Northstar (April 2022) and Sapienza (July 2022), negotiations regarding the potential disposal of Westek are continuing with a preferred buyer. The valuation is modest and there is no certainty that a transaction will be completed. An alternative strategy to retain Westek within the Group will be implemented if a transaction is not concluded.

 

Group Financing

 

The current aggregate facilities (HSBC and Science Group) total £11 million of which approximately £7.0 million is currently drawn, including the bank facility which remains fully drawn at approximately £6 million. In recent months, the Group has partially drawn on the Science Group standby facility in order to fund working capital requirements. Current cash flow forecasts indicate that the Science Group facility may continue to be required in the coming months. 

 

The current bank facility and the Science Group standby facility expire in September 2023. The Board does not anticipate either facility will be renewed and therefore alternative funding arrangements will need to be in place by the end of the year in order for the Group to satisfy the requirements in relation to financial reporting as a going concern. While the Board has initiated discussions to explore potential alternative financing sources, it is apparent that a pre-condition to any refinancing is that the legacy TPGM contracts are satisfactorily resolved. Furthermore, in the current UK economic environment, there is no certainty that new debt facilities will be available on terms which are acceptable or can be agreed in a timely manner.

 

The Board has not ruled out the possibility of an equity fund raise, but it recognises that at the current share price such a refinancing would likely result in a significant dilution of existing shareholders who did not or were unable to participate.

 

Summary

 

The onerous nature of the legacy TPGM contracts became apparent in late 2021 and early 2022. The materiality and seriousness of the situation progressively escalated during the subsequent months. Ultimately, these contracts placed the future of the Maritime subsidiary, and potentially the entire Group, in jeopardy. The new management team installed at TPGM, led by a senior manager seconded from Science Group, has brought a new rigour and discipline to the division enabling the contracts to be renegotiated, a serious financial solvency crisis to be averted and implementation of necessary operational and commercial improvements.

 

To remain as an independent company, the capital structure of the Group needs to be addressed. It is not certain that any refinancing can be completed on terms which would be acceptable to the Board or TP Group shareholders.

 

 

Recommended Offer by Science Group plc

 

While the TPGM contract negotiations are ongoing, sufficient progress has been made which, together with the disposals of the non-core operations, has enabled the Independent Directors and Science Group plc to agree terms for a recommended offer for TP Group plc ("Offer") at a significant premium to the current share price. The Independent Directors of TP Group strongly recommend that shareholders accept the Offer, which is anticipated to be implemented by a Scheme of Arrangement. Details of the Offer are set out in a separate announcement released today.

 

Contact:

TP Group plc

Tel: 01753 285802

Martyn Ratcliffe, Executive Chairman

Derren Stroud, Chief Financial Officer

www.tpgroupglobal.com

Cenkos Securities plc

Tel: 020 7397 8980

Stephen Keys / Mark Connelly / Callum Davidson

www.cenkos.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGZMFGZGLGZZZ
Date   Source Headline
18th Apr 201911:12 amRNSPublication of Annual Report and Notice of AGM
18th Apr 20197:00 amRNSHolding(s) in Company
17th Apr 201912:45 pmRNSHolding(s) in Company
4th Apr 20197:00 amRNSSpace systems contract extensions
3rd Apr 20197:00 amRNSContract renewal
2nd Apr 20197:00 amRNSFinal Results for the year ending 31 December 2018
12th Mar 20193:07 pmRNSHolding(s) in Company
5th Feb 20197:00 amRNSOrder for Carbon Dioxide management equipment
30th Jan 20197:00 amRNSFollow-on order for Carbon Dioxide equipment
22nd Jan 20197:00 amRNSAdditional Contract for Nuclear Systems
15th Jan 20197:00 amRNSTrading Update and Notice of Results
13th Dec 20187:00 amRNSChange of FTSE sector classification
3rd Dec 20187:00 amRNSHolding(s) in Company
20th Nov 20187:00 amRNSRugged systems order worth c.£0.75m from UAE
5th Nov 20187:00 amRNSAcquisition of Westek Technology Ltd
10th Oct 20187:00 amRNSTP Group awarded £0.9m defence research funding
28th Sep 20182:00 pmRNSHoldings in Company
11th Sep 20187:00 amRNSInterim Results
7th Aug 20187:00 amRNSNotice of Results
16th Jul 20187:00 amRNSTrading Update
25th Jun 20187:00 amRNSSecures £2m export defence equipment contract
7th Jun 201812:00 pmRNSResult of AGM
7th Jun 20188:10 amRNSFramework agreement with Naval Group
7th Jun 20187:00 amRNSAGM Statement
24th May 20187:00 amRNSUS Partnership
14th May 20188:45 amRNSPublication of Annual Report and Notice of AGM
2nd May 20187:00 amRNSContract Award
30th Apr 20187:00 amRNSMoD contract awards
20th Apr 201812:50 pmRNSHoldings in Company
17th Apr 20187:00 amRNSFinal results for the year ended 31 December 2017
9th Apr 20188:25 amRNSArmy Headquarters Programme Support contract win
26th Mar 201810:22 amRNSInformation Assurance contract win
23rd Mar 20187:00 amRNSNotice of Results
22nd Mar 20187:00 amRNSCarbon dioxide equipment contract win
13th Mar 201812:50 pmRNSHoldings in Company
12th Feb 20187:00 amRNSOpening of Advanced Manufacturing Centre
9th Feb 20183:14 pmRNSBoard Change
15th Jan 20187:00 amRNSTrading Update and Notice of Results
9th Jan 20187:00 amRNSDefence refurbishment contract win
14th Dec 20177:00 amRNSContract Win
13th Dec 20177:00 amRNSAcquisition of Polaris Consulting Holdings Ltd
12th Dec 20177:00 amRNSExport defence contract win
14th Nov 20177:00 amRNS£770k Defence Contract Award
20th Sep 20172:50 pmRNSHolding(s) in Company
20th Sep 20172:05 pmRNSHolding(s) in Company
12th Sep 20177:00 amRNSInterim Results
31st Aug 20174:25 pmRNSHoldings in Company
2nd Aug 20171:00 pmRNSHolding(s) in Company
2nd Aug 20171:00 pmRNSHolding(s) in Company
1st Aug 20174:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.